RecruitingNot ApplicableNCT05784805

Acute Effects of Focused Ultrasound Modulation on EEG Behavior in Status Epilepticus Patients


Sponsor

Yale University

Enrollment

10 participants

Start Date

Jun 24, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

In this study, the investigators propose Pulsed Low-Intensity Focused Ultrasound (PLIFU) stimulation of brain regions that modulate (thalamus) or generate focal motor seizures (primary motor cortex), with the goal of ameliorating seizure activity in subjects in non-convulsive or focal motor status epilepticus. The course of treatment will consist of an initial 10 minute PLIFU treatment session with an option for a 2nd session if necessary. The primary objective of this study is to determine whether PLIFU reduces or suppresses epileptic activity in patients with Non-Convulsive Status Epilepticus (NCSE)/Focal Motor Status Epilepticus (FMSE) that have not responded to standard of care.


Eligibility

Min Age: 19 YearsMax Age: 85 Years

Inclusion Criteria3

  • Subjects diagnosed with ongoing NCSE or FMSE despite treatment with at least 2 ASMs
  • Provision of signed and dated informed consent form obtained from the next-of-kin/legally authorized representative
  • Treated in the ICU while monitored with continuous scalp EEG electrodes

Exclusion Criteria7

  • Unable to obtain informed consent
  • Presence of an implanted cranial neuromodulation device for treatment of epilepsy
  • Pregnancy
  • Treatment with another investigational drug or other intervention within 24 hr
  • Presence of burr hole(s) or craniotomy
  • Subjects with ferromagnetic materials in the head
  • Subjects with a TENS unit

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEPLIFU

Participants will be treated with up to 2 sessions of PLIFU (on the same day), while monitored with surface EEG and will be observed for the remainder of the hospital stay as deemed by the primary care team. The system non-invasively delivers ultrasound sonications intracranially that selectively target specific areas of the brain.


Locations(1)

Yale New Haven Hospital

New Haven, Connecticut, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05784805


Related Trials